Menu
  • The 6th annual E-Cigarette Summit will take place on Thursday 15th November 2018 at The Royal Society, London
  • The 2017 speaker videos are now available on the "Resources" page
  • The 2nd US E-Cigarette Summit will take place in Washington 30th April 2018

Welcome to The E-Cigarette Summit 2018

Since the inaugural meeting in November 2013, The E-Cigarette Summit has been at the forefront of taking forward the scientific and public health debate around e-cigarettes and broader harm reduction debates. The Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals and stakeholders to come together and look at the latest scientific research and evidence on e-cigarettes and debate their impact. In 2013, the conversation was UK centric as the public health and policy communities sought to find an appropriate regulatory system for e-cigarettes that would reflect the opportunities for smokers without ignoring potential harms.  In the intervening years, the UK has emerged as an active proponent for tobacco harm reduction alongside stringent tobacco control measures and now six years on the Summit welcomes  scientists, public health professionals and policy makers from around the world who are looking to establish their own regulatory framework in the face of new nicotine products.

Alongside the latest evidence on the safety of e-cigarettes for users and bystanders, The E-Cigarette Summit will continue to address broader debates including evidence on “gateway” for youth and non-smokers, advertising and marketing, use in public places and the conflicts arising from the tobacco industry’s dual corporate ownership of tobacco harm reduction products and cigarettes.  The role that e-cigarettes could play in ending or extending the smoking epidemic will remain one of the most fiercely fought debates in public health history.

For governments and policy makers/advisors, the weight of making the right decision cannot be underestimated.  From outright bans, advertising restrictions to higher taxation; the way that each country introduces, interprets and implements legislation, including consumer and medical licensing routes, will have far reaching consequences.  Setting the regulatory bar at the correct level, will be vital to harnessing the opportunities that e-cigarettes and reduced harm nicotine products could offer to those most in need, while remaining responsive to a tobacco control manifesto to reduce smoking related harm.

What questions will be explored?

The E-Cigarette Summit will include high level briefings from experts and encourages interaction through panel debates and open floor discussions.  Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints. The E-Cigarette Summit will explore the latest research and evidence on the following areas:

  • Communicating risks and benefits – are we getting the regulatory policies right?
  • What can we learn from the Scandinavian experience about the impact of tobacco harm reduction
  •  E-cigarettes and history, why countries have different policies yet share the same evidence
  • How to manage unanswered questions in tobacco harm reduction research
  • Why are LMIC countries typically favouring restrictive policies toward e-cigarettes
  • Does the” JUUL Phenomenon” change the public health calculations for e-cigarettes
  • Why is the US reporting a surge in youth use which has not been seen in the UK
  • Disentangling the gateway hypothesis using a variety of methodological and analytical approaches
  • Do e-cigarettes help smokers to quit and should clinicians recommend e-cigarettes to all smokers
  • Flavours and why they are important to consumers and public health
  • Harm reduction for all – how do we reach those most in need but hardest to work with
  • Understanding the different product categories
  • Flavours and why they are important to consumers and public health

Who should attend?

In particular, this event will be relevant to:

  • Regulators and policy advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health charities and health campaigners
  • Public health professionals and academics
  • Medical professionals
  • Industry stakeholders

The Summit independently provides hosted places for vapers and individuals without funding to attend, but are important stakeholders in the harm reduction debate .  These places are discretionary and are considered on a case by case basis.  If you would like to find out more please contact us.